Nikhil Prasad Fact checked by:Thailand Medical New Team Jul 18, 2026 56 minutes ago
Medical News: For years, artificial and low-calorie sweeteners have been promoted as healthier substitutes for sugar, helping millions of people reduce calorie intake without sacrificing sweetness. They are found in everything from diet sodas and sugar-free desserts to chewing gum, breakfast cereals, medicines, and nutritional supplements. But a groundbreaking new study suggests these widely used ingredients may not be as biologically inactive as previously believed.
Researchers have discovered that many commonly used sweeteners can directly alter the growth of beneficial gut bacteria. Even more surprising, the effects can become significantly stronger when sweeteners are consumed alongside common medications, food additives, or ingredients found in everyday foods and beverages. The findings raise new questions about how these compounds may influence human health through unexpected interactions inside the gut.
Laboratory scientists discovered that common sweeteners can directly alter beneficial gut bacteria, especially
when combined with certain medications such as duloxetine.
Scientists from the Medical Research Council (MRC) Toxicology Unit at the University of Cambridge, United Kingdom, carried out one of the most comprehensive laboratory investigations ever conducted into how commercial sweeteners affect the gut microbiome. Their findings suggest that the biological activity of sweeteners is far more complex than previously understood and may depend heavily on what other substances people consume at the same time.
The Gut Microbiome Plays a Much Bigger Role Than Many Realize
The human digestive tract is home to trillions of microorganisms collectively known as the gut microbiome. This enormous microbial ecosystem performs countless vital functions that extend well beyond digestion.
Beneficial bacteria help break down complex carbohydrates that humans cannot digest on their own. During this process they produce valuable compounds known as short-chain fatty acids, including butyrate and propionate, which nourish the cells lining the colon, help regulate blood sugar metabolism, strengthen the intestinal barrier, and influence immune activity throughout the body.
Scientists increasingly recognize that disturbances in the gut microbiome have been associated with obesity, diabetes, inflammatory bowel disease, allergies, autoimmune disorders, cardiovascular disease, neurological conditions, and even mental health disorders. While many studies have linked artificial sweeteners with some of these conditions, the biological mechanisms responsible have remained unclear.
Previous research often relied on animal studies or observations in large populations, making it difficult to determine whether sweeteners directly affected gut bacteria or whether other factors explained the associations. The Cambridge researchers wanted to answer a much more fundamental question: do sweeteners themselves directly interact with gut microbes?
An Unprecedented Laboratory Investigation
To answer this question, the research team assembled an unusually diverse collection of gut microorganisms.
They selected 25 bacterial species representing benefi
cial microbes, neutral residents, probiotic strains, and organisms that can become harmful under certain circumstances. These bacteria collectively represented a broad cross-section of organisms commonly found in healthy human intestines.
The scientists then tested 39 commercially available sweeteners and sugar substitutes, including both artificial and naturally derived products currently used throughout the global food industry.
Rather than studying entire microbial communities immediately, they first examined each bacterial species individually. This approach allowed them to determine precisely which sweeteners influenced which bacterial strains without interference from neighboring microbes.
Each bacterium was grown under carefully controlled laboratory conditions before being exposed to individual sweeteners. Researchers closely monitored bacterial growth to determine whether each sweetener stimulated growth, slowed multiplication, or completely inhibited survival.
The scale of the study allowed thousands of individual interactions between bacteria and sweeteners to be evaluated systematically, creating one of the most detailed interaction maps produced to date.
Three-Quarters of Sweeteners Altered Bacterial Growth
The results surprised even the researchers. Approximately 75 percent of all sweeteners tested affected the growth of at least one bacterial species.
Some sweeteners had only modest effects, while others significantly slowed bacterial multiplication or nearly stopped growth altogether. Several of the most affected organisms were bacteria generally regarded as beneficial members of the healthy gut microbiome.
These findings challenge the long-standing assumption that many sweeteners simply pass through the digestive tract without directly interacting with microorganisms living there.
Instead, the study indicates that numerous sweeteners possess biological activity capable of reshaping microbial populations under laboratory conditions.
While this does not automatically mean they cause disease in humans, it suggests these compounds deserve much closer investigation than they have received previously.
Researchers Studied Real-Life Consumption Patterns
Most previous laboratory experiments have focused on single ingredients tested in isolation.
However, people rarely consume sweeteners alone. A diet soda contains caffeine. A dessert may include vanilla flavoring. Medicines frequently contain sweeteners to mask bitterness. Many processed foods combine multiple sweeteners with numerous additives.
Recognizing this reality, the Cambridge researchers expanded their investigation to examine what happens when sweeteners encounter other commonly consumed compounds.
The team tested sweeteners alongside caffeine, vanillin (the primary flavor compound responsible for vanilla), another artificial sweetener called advantame, and several widely prescribed medications.
This approach better reflected the complex chemical environment that exists inside the human digestive system after meals or medications are consumed.
More Than One Hundred Hidden Chemical Interactions Emerged
The second phase of the study revealed an entirely new level of complexity.
Researchers identified over 100 separate interactions where another compound altered the effect of a sweetener on gut bacteria.
Some combinations became considerably more damaging than either substance alone, while others unexpectedly weakened previously observed effects.
Specifically, scientists documented 34 synergistic interactions, where the combined effects were stronger than expected, and 68 antagonistic interactions, where one compound partially reduced the biological impact of another.
These findings suggest that evaluating a sweetener by itself may not provide an accurate picture of how it behaves inside the body.
Instead, its biological effects could vary depending upon an individual's medications, diet, beverages, or other food ingredients consumed at the same time.
This concept of "mixture effects" has long been recognized in pharmaceutical science but has received relatively little attention in nutritional research.
One Combination Produced Especially Concerning Results
Among all combinations examined, one stood out dramatically. Researchers discovered that isosteviol, a sweetener component used within the food industry, became substantially more disruptive when combined with duloxetine, a commonly prescribed antidepressant used to treat depression, anxiety disorders, diabetic nerve pain, fibromyalgia, and chronic musculoskeletal pain.
Together, these two compounds strongly suppressed the growth of two particularly important bacterial species:
-Roseburia intestinalis
-Parabacteroides merdae
Roseburia intestinalis is especially valuable because it produces butyrate, one of the most beneficial short-chain fatty acids generated inside the colon. Butyrate serves as the primary energy source for colon cells while also supporting intestinal barrier integrity and helping regulate inflammation.
Parabacteroides merdae has also been associated with healthy microbial communities and appears to contribute to metabolic regulation and digestive health.
The combined suppression of both organisms raised concerns that certain sweetener-drug combinations could potentially disturb important microbial functions more than either compound alone.
Importantly, duloxetine is widely prescribed worldwide, making these findings particularly relevant for future clinical research.
Scientists Built an Artificial Gut Community
The researchers understood that bacteria rarely live alone inside the human intestine.
To better mimic natural conditions, they created a simplified synthetic microbial community containing all 25 bacterial species growing together. This allowed scientists to observe how bacterial populations shifted when exposed to sweetener-drug combinations while competing and interacting with one another.
Instead of merely measuring whether individual bacteria survived, they could observe broader ecological changes similar to those occurring within the human gut.
The artificial community revealed that the isosteviol-duloxetine combination altered the balance of bacterial populations, allowing some species to expand while beneficial organisms declined.
Even more concerning, the overall microbial diversity decreased substantially.
Loss of Microbial Diversity Could Have Wider Health Implications
One of the most significant observations from the study was the reduction in overall microbial diversity after exposure to the combination of isosteviol and duloxetine. Scientists generally regard a diverse gut microbiome as a hallmark of good digestive health because a wider variety of bacterial species provides greater resilience against infections, dietary changes, and environmental stressors.
When diversity declines, beneficial bacteria may become less abundant while other species gain an advantage, potentially disrupting the balance that keeps the digestive system functioning normally. Although every individual has a unique microbiome and there is no single "perfect" microbial composition, maintaining diversity is widely considered important for long-term health.
The researchers found that the sweetener-drug combination did not simply eliminate bacteria. Instead, it reshaped the microbial ecosystem, altering which organisms flourished and which struggled to survive. Such shifts could influence the production of many microbial compounds that communicate with the immune system and other organs throughout the body.
Important Metabolites Were Also Altered
Beyond measuring bacterial growth, the scientists performed detailed proteomic, metabolomic, and genetic analyses to understand why these microbial changes occurred.
Their investigations showed that the combination of isosteviol and duloxetine altered bacterial transport systems responsible for moving small molecules into and out of microbial cells. These changes appeared to underlie the powerful synergistic effects observed during the experiments.
Perhaps even more importantly, the altered bacterial community produced lower amounts of butyrate and propionate, two short-chain fatty acids that play essential roles in maintaining intestinal health.
Butyrate serves as the primary energy source for cells lining the colon and helps strengthen the intestinal barrier that prevents harmful substances from leaking into the bloodstream. It also helps regulate inflammation and supports the normal development of immune cells.
Propionate contributes to glucose regulation, lipid metabolism, and maintaining the integrity of the gut lining. Together, these molecules are considered among the most beneficial products generated by healthy gut bacteria.
A reduction in these microbial metabolites does not automatically mean disease will occur, but it suggests that disturbing certain bacterial populations could influence many biological processes beyond digestion.
Changes Extended Beyond the Bacteria Themselves
The research team also investigated whether the altered bacterial communities affected human cells.
Using laboratory-grown HeLa cells and Caco-2 intestinal epithelial cells, they exposed the cells to substances produced by the modified bacterial communities. The results showed increased toxicity toward certain host cells after bacteria had been exposed to the isosteviol-duloxetine combination. In addition, secretion of the important signaling molecules interleukin-6 (IL-6) and interleukin-8 (IL-8) was altered.
These cytokines help regulate immune responses and inflammation within the digestive tract. Under normal circumstances they contribute to defending against invading pathogens while also helping repair damaged intestinal tissue.
The observed reduction in IL-6 and IL-8 suggests that certain sweetener-drug combinations might influence communication between gut bacteria and the immune system. However, the researchers stress that immune signaling is highly complex, and changes observed in laboratory cell models cannot be directly translated into effects in people.
A New Direction for Nutrition and Drug Research
This
Medical News report highlights a growing realization among scientists that foods, food additives, medications, and the gut microbiome should not be studied independently. Instead, they form a highly interconnected biological network where combinations of compounds may produce effects that would never be predicted by examining individual ingredients alone.
The Cambridge study represents one of the first systematic attempts to map these complex interactions across dozens of commercially used sweeteners and multiple commonly consumed compounds. The researchers believe their work provides a valuable foundation for future investigations into personalized nutrition and medicine. As scientists learn more about how different foods and medications influence gut microbes, healthcare providers may eventually be able to better predict which combinations are most suitable for individual patients based on their unique microbiome.
Conclusion
The findings from this extensive laboratory investigation challenge the long-held belief that low-calorie sweeteners simply pass through the digestive system without interacting with the body's microbial residents. By demonstrating that approximately three-quarters of the tested sweeteners directly influenced the growth of at least one gut bacterial species—and that more than one hundred interactions emerged when these sweeteners were combined with medications, caffeine, or flavorings—the study opens an entirely new field of research.
Particularly noteworthy was the interaction between isosteviol and the antidepressant duloxetine, which reduced beneficial bacteria, lowered microbial diversity, altered the production of health-promoting metabolites such as butyrate and propionate, and changed immune-related signaling in laboratory cell models. Nevertheless, these experiments were performed in vitro and should not be interpreted as evidence that similar effects definitely occur in humans. Much larger animal and clinical studies will be needed to determine whether these microbial changes happen under real-life conditions and whether they have meaningful health consequences. Until then, the research serves as an important reminder that ingredients previously considered biologically neutral may participate in surprisingly complex interactions inside the gut, emphasizing the need for more comprehensive studies of how diet, medications, and the microbiome work together to influence human health.
The study findings were published in the peer reviewed journal: Molecular Systems Biology.
https://link.springer.com/article/10.1038/s44320-026-00225-6
For the latest on adverse effects of using sweeteners, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/news/artificial-sweeteners-tied-to-faster-brain-aging-risk-and-cognitive-issues
https://www.thailandmedical.news/news/erythritol-a-common-artificial-sweetener-increases-risk-of-clots-and-stroke
https://www.thailandmedical.news/news/new-alarming-discovery-that-the-sweetener-sorbitol-causes-liver-damage
https://www.thailandmedical.news/news/warning-new-generation-artificial-sweetener-neotame-causes-dysbiosis-and-damages-gut-walls
https://www.thailandmedical.news/news/breaking-news-consumption-of-the-artificial-sweetener-aspartame-linked-to-learning-and-memory-deficits-that-are-passed-to-offspring
https://www.thailandmedical.news/news/breaking-news-study-finds-that-sucralose,-an-artificial-sweetener,-disrupts-the-immune-system-by-decreasing-activation-of-t-cells
https://www.thailandmedical.news/news/ucla-study-shows-that-artificial-sweeteners-like-stevia,-saccharin-and-sucralose-causes-glycemic-response-impairment-via-gut-microbiome
https://www.thailandmedical.news/news/fructose-sweeteners-university-of-california-study-shows-that-excessive-fructose-intake-may-cause-leaky-gut-which-in-turn-leads-to-fatty-liver-disease
https://www.thailandmedical.news/news/university-of-south-australia-researchers-shows-that-artificial-sweeteners-actually-causing-more-health-damage
Share
Tweet
Share
